Acupuncture showed better improvement than sham acupuncture in reducing attack frequency of tension-type headache (TTH), but its effectiveness relative to first-line drugs for TTH is unknown, whi...
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01776-5
Calcitonin gene-related peptide (CGRP) is the most promising candidate to become the first migraine biomarker. However, literature shows clashing results and suggests a methodological source for ...
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01769-4
Several studies have focused on the use of triptan and the risk of acute vascular events but the existence of such association is still debated and has never been quantified in patients over 65 y...
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01770-x
Despite recent advancements in migraine treatment, some patients continue to endure significant disease burden. Due to the controlled nature of randomized trials in migraine prevention, many real...
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01764-9
We have previously shown headache to be highly prevalent among adults in Saudi Arabia. Here we estimate associated symptom burden and impaired participation (impaired use of time, lost productivi...
https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01767-6